Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary Sjögren’s Syndrome
Jean‐Pascal Lefaucheur, D. Sène, Anne Louise Oaklander
New England Journal of Medicine (2018) Vol. 379, Iss. 1, pp. 96-97
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Update on the pathophysiology and treatment of primary Sjögren syndrome
Chiara Baldini, Giovanni Fulvio, Gaetano La Rocca, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 8, pp. 473-491
Closed Access | Times Cited: 21
Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy
Anne Louise Oaklander, Maria Nolano
JAMA Neurology (2019) Vol. 76, Iss. 10, pp. 1240-1240
Open Access | Times Cited: 122
Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sjögren’s Syndrome
Xiaoping Hong, Shuhui Meng, Donge Tang, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 75
LAMP3 inhibits autophagy and contributes to cell death by lysosomal membrane permeabilization
Tsutomu Tanaka, Blake M. Warner, Drew G. Michael, et al.
Autophagy (2021) Vol. 18, Iss. 7, pp. 1629-1647
Open Access | Times Cited: 64
A Link Between Mitochondrial Dysfunction and the Immune Microenvironment of Salivary Glands in Primary Sjogren’s Syndrome
Ning Li, Yusi Li, Jiawei Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
B Cells Dynamic in Aging and the Implications of Nutritional Regulation
Yifei Yu, Chenxu Lu, Weiru Yu, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 487-487
Open Access | Times Cited: 9
Role of Viral Infections in the Pathogenesis of Sjögren’s Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1
Hideki Nakamura, Toshimasa Shimizu, Atsushi Kawakami
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1459-1459
Open Access | Times Cited: 40
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Thomas Dörner, Martin Kaul, Antónia Szántó, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 3, pp. 360-371
Open Access | Times Cited: 14
Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology
Xiao Li, Maierhaba Maitiyaer, Qing Tan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
CD8+tissue-resident memory T cells are expanded in primary Sjögren’s disease and can be therapeutically targeted by CD103 blockade
Daniele Mauro, Xiang Lin, Elena Pontarini, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 10, pp. 1345-1357
Open Access | Times Cited: 5
The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
Xuan Wang, Tongyangzi Zhang, Zizhen Guo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
Age-associated B cell infiltration in salivary glands represents a hallmark of Sjögren’s-like disease in aging mice
Harini Bagavant, Justyna Durślewicz, Marcelina Pyclik, et al.
GeroScience (2024) Vol. 46, Iss. 6, pp. 6085-6099
Closed Access | Times Cited: 4
Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren’s syndrome (pSS) via suppressing NF-κb signaling pathway
Hong Zhu, Jian Zheng, Yan Zhou, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 5, pp. 2029-2037
Closed Access | Times Cited: 24
Rituximab Therapy for Primary Sjögren’s Syndrome
Yi Han Chen, Xin Yu Wang, Xin Jin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23
Single Cell RNA Sequencing in Autoimmune Inflammatory Rheumatic Diseases: Current Applications, Challenges and a Step Toward Precision Medicine
Tadeja Kuret, Snežna Sodin‐Šemrl, Brane Leskošek, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 17
Childhood-onset primary Sjögren’s syndrome in a tertiary center in China: clinical features and outcome
Yinv Gong, Haimei Liu, Guomin Li, et al.
Pediatric Rheumatology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
CXCL9 may serve as a potential biomarker for primary Sjögren’s syndrome with extra-glandular manifestations
Jingwei Hong, Hui Cheng, Ping Wang, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 3
Long Non-Coding RNAs in Sjögren’s Disease
Ondřej Pastva, Kerstin Klein
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5162-5162
Open Access | Times Cited: 3
Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37
Pio Conti, Luisa Stellin, Alesssandro Caraffa, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4297-4297
Open Access | Times Cited: 24
Autoantibodies identify primary Sjögren’s syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B
Sherri Longobardi, Charmaine Lopez-Davis, Bhuwan Khatri, et al.
Annals of the Rheumatic Diseases (2023), pp. ard-223105
Open Access | Times Cited: 7
MANF inhibits Sjögren's syndrome salivary gland epithelial cell apoptosis and antigen expression of Ro52/SSA through endoplasmic reticulum stress/autophagy pathway
Danqian Cheng, Tongtong Zhou, Hui Liu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110582-110582
Closed Access | Times Cited: 7
Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren’s syndrome
Nan Xiang, Hao Xu, Zhou Zhou, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107943-107943
Open Access | Times Cited: 7
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort
Lisa Christ, Seraphina Kissling, Axel Finckh, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets
Jacob Ritter, Franziska Szelinski, Arman Aue, et al.
Journal of Autoimmunity (2024) Vol. 147, pp. 103243-103243
Open Access | Times Cited: 2
Advances in cellular and molecular pathways of salivary gland damage in Sjögren’s syndrome
Wenxia Qi, Jiexiang Tian, Gang Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top